Neuromuscular disorders (NMDs) represent a broad spectrum of diseases affecting peripheral nerves, muscles, and neuromuscular junctions.
These disorders may be inherited, like muscular dystrophies, or acquired, such as myasthenia gravis. Genetic mutations, immune system dysfunctions, and environmental factors contribute to the etiology.
Common symptoms include muscle weakness, cramps, stiffness, and twitching. More severe cases may result in mobility issues or respiratory failure.
Treatments vary widely, encompassing physiotherapy, medication, surgery, and lifestyle modifications.
Understanding NMDs is crucial for healthcare professionals to provide optimal patient care and management.
1.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
Patients face high out-of-pocket costs after incident cancer diagnosis
5.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
3.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
4.
Unveiling the Mystery Behind Lymphovascular Invasion
5.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation